Moderna, Inc. Shares Outstanding (Cover Page)
Moderna, Inc. (MRNA) had Shares Outstanding (Cover Page) of 399.24 million shares as of 2026-07-24, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-31
- 2026-07-24: Entity Common Stock, Shares Outstanding 399.24M shares.
- 2026-04-24: Entity Common Stock, Shares Outstanding 396.79M shares.
- 2026-02-13: Entity Common Stock, Shares Outstanding 394.94M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 390.68M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-24 | 399.24M shares 10-Q · filed 2026-07-31 |
| 2026-04-24 | 396.79M shares 10-Q · filed 2026-05-01 |
| 2026-02-13 | 394.94M shares 10-K · filed 2026-02-20 |
| 2025-10-31 | 390.68M shares 10-Q · filed 2025-11-06 |
| 2025-07-25 | 389.08M shares 10-Q · filed 2025-08-01 |
| 2025-04-25 | 386.74M shares 10-Q · filed 2025-05-01 |
| 2025-02-14 | 385.82M shares 10-K · filed 2025-02-21 |
| 2024-10-31 | 384.82M shares 10-Q · filed 2024-11-07 |
| 2024-07-26 | 384.40M shares 10-Q · filed 2024-08-01 |
| 2024-04-26 | 383.24M shares 10-Q · filed 2024-05-02 |
| 2024-02-16 | 382.07M shares 10-K · filed 2024-02-23 |
| 2023-10-27 | 381.28M shares 10-Q · filed 2023-11-03 |
| 2023-07-31 | 380.59M shares 10-Q · filed 2023-08-03 |
| 2023-04-28 | 381.21M shares 10-Q · filed 2023-05-04 |
| 2023-02-17 | 386.34M shares 10-K · filed 2023-02-24 |
| 2022-10-31 | 384.18M shares 10-Q · filed 2022-11-03 |
| 2022-07-29 | 391.20M shares 10-Q · filed 2022-08-03 |
| 2022-04-29 | 397.76M shares 10-Q · filed 2022-05-04 |
| 2022-02-18 | 402.87M shares 10-K · filed 2022-02-25 |
| 2021-10-29 | 405.45M shares 10-Q · filed 2021-11-04 |
| 2021-07-30 | 403.65M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 401.53M shares 10-Q · filed 2021-05-06 |
| 2021-02-16 | 399.77M shares 10-K · filed 2021-02-26 |
| 2020-10-20 | 395.71M shares 10-Q · filed 2020-10-30 |
| 2020-07-31 | 394.59M shares 10-Q · filed 2020-08-06 |
| 2020-04-30 | 371.22M shares 10-Q · filed 2020-05-07 |
| 2020-02-26 | 368.64M shares 10-K · filed 2020-02-27 |
| 2019-10-31 | 333.25M shares 10-Q · filed 2019-11-06 |
| 2019-07-31 | 330.18M shares 10-Q · filed 2019-08-08 |
| 2019-04-29 | 329.00M shares 10-Q · filed 2019-05-09 |
| 2019-03-06 | 329.00M shares 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |